Literature DB >> 14981989

Adhesion molecule CD44 as a prognostic factor in tongue cancer.

Miguel Angel Gonzalez-Moles1, Manuel Bravo, Isabel Ruiz-Avila, Francisco Esteban, Alberto Rodriguez-Archilla, Salvador Gonzalez-Moles, Bartolome Arias.   

Abstract

BACKGROUND: Loss of expression of CD44 has been shown to be a factor of poor prognosis in some types of tumors. The purpose of this study was to analyze this in relation to the survival of patients with tongue cancer.
MATERIALS AND METHODS: The expression of adhesion molecule CD44 was studied in 56 patients with tongue cancer. Data were gathered on clinical (T, N, M and stage) and pathological (T, N, stage, extracapsular spread, differentiation, tumor thickness, surgical margin and CD44 expression) parameters. Immunohistochemistry studies were carried out using DF1485 anti-CD44 monoclonal antibody.
RESULTS: In five tumors (8.9%) < 25%, in 11 (19.6%) 25%-49%, in 15 (26.8%) 50%-74% and in 25 (44.6%) > or = 75% of the neoplastic cells expressed CD44. A Cox proportional risks multivariate analysis identified CD44 expression as the parameter most associated with survival (p < 0.001).
CONCLUSION: The reduced expression of CD44 behaves as a marker of poor tongue tumor prognosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14981989

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  CD44 expression in intraoral salivary ductal papillomas and oral papillary squamous cell carcinoma.

Authors:  Sarah G Fitzpatrick; Lindsay J Montague; Donald M Cohen; Indraneel Bhattacharyya
Journal:  Head Neck Pathol       Date:  2012-11-13

2.  Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.

Authors:  Snehal Navnath Dhumal; Sheetal Korde Choudhari; Sangeeta Patankar; Shrikrishna S Ghule; Yogesh B Jadhav; Sneha Masne
Journal:  Head Neck Pathol       Date:  2021-10-16

3.  Co-expression of CD44+/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma.

Authors:  Martin Grimm; Cornelius Renz; Adelheid Munz; Sebastian Hoefert; Michael Krimmel; Siegmar Reinert
Journal:  Odontology       Date:  2013-08-25       Impact factor: 2.634

Review 4.  Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.

Authors:  Jianqiang Chen; Jianding Zhou; Jie Lu; Hua Xiong; Xueli Shi; Liang Gong
Journal:  BMC Cancer       Date:  2014-01-13       Impact factor: 4.430

Review 5.  Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.

Authors:  Muneyuki Masuda; Satoshi Toh; Takahiro Wakasaki; Masumi Suzui; Andrew K Joe
Journal:  Mol Oncol       Date:  2012-11-02       Impact factor: 6.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.